Skip to main content
Eli Lilly and Company (SWX:LLY)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
815.00
-20.00 (-2.40%)
At close: Dec 4, 2025

Eli Lilly and Company Revenue

Eli Lilly and Company had revenue of $17.60B USD in the quarter ending September 30, 2025, with 53.87% growth. This brings the company's revenue in the last twelve months to $59.42B, up 45.41% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.

Revenue (ttm)
$59.42B
Revenue Growth
+45.41%
P/S Ratio
15.37
Revenue / Employee
$1.26M
Employees
47,000
Market Cap
728.45B CHF

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202445.04B10.92B32.00%
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 202024.54B2.22B9.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 63.49B
Novartis AG 44.95B
Lonza Group AG 7.09B
Galderma Group AG 3.73B
Alcon 8.12B
Sandoz Group AG 8.42B
Straumann Holding AG 2.58B
Sonova Holding AG 3.85B
Revenue Rankings

Eli Lilly and Company News

More News